account_balance
Investment manager · 13F filer · SEC CIK 1274403
ARCH Venture Management, LLC
Reported value$1.1Bas of Jun 30, 2026
Positions12 3 new, 1 sold out
Top 10 weight99%PBLS alone is 16%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PBLS
Parabilis Medicines INC
16.0%New
BEAM
Beam Therapeutics INC
14.2%
RAPP
Rapport Therapeutics INC
14.1%
SPTX
Seaport Therapeutics INC
12.4%New
ERAS
Erasca INC
11.8%
VIR
Vir Biotechnology INC
11.8%
MAZE
Maze Therapeutics INC
11.2%
LYEL
Lyell Immunopharma INC
4.1%
GENB
Generate Biomedicines INC
3.0%
TXG
0.8%
2 others
0.7%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed